New drug may shorten jaundice in gallstone patients

NCT ID NCT05928286

Completed Disease control Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a drug called Remaxol can help people with gallstones and a serious complication called obstructive jaundice. Obstructive jaundice happens when a gallstone blocks the bile duct, causing yellowing of the skin and eyes. The study involved 286 adults who were scheduled for two surgeries to remove the blockage and then the gallbladder. Researchers wanted to see if giving Remaxol around the time of surgery could shorten the jaundice and lower the risk of complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GALLSTONE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cholelithiasis gallstones obstructive jaundice

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GALLSTONE DISEASE OBSTRUCTIVE JAUNDICE

Contacts and locations

Locations

City Clinical Hospital No. 7

Nizhny Novgorod, Russia
Dzhanelidze St. Petersburg Research Institute of Emergency Medicine

Saint Petersburg, Russia
Hospital for War Veterans

Kazan', Russia
Krai Clinical Hospital

Barnaul, Russia
Kuvatov Republican Clinical Hospital

Ufa, Russia
Mirotvortsev University Clinical Hospital No. 1

Saratov, Russia
Pavlov Ryazan State Medical University

Ryazan, Russia
Samara State Medical University

Samara, Russia
St. Elizabeth Hospital

Saint Petersburg, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.